A new method of reversing Alzheimer's shows promise in an animal study, as researchers at University Hospitals restore brain ...
A nationwide survey by the Alzheimer’s Association in 2025 found close to 4 in 5 Americans 45 and older want to know if they ...
Alzheimer’s disease blood test developer Quanterix put forward new clinical data from its Simoa assay, which it described as ...
IFLScience on MSN
Experimental Alzheimer’s drug could have the power to halt disease before symptoms even start
A breakthrough new Alzheimer’s disease treatment is stopping neurodegeneration in its tracks, even before symptoms appear.
From robotic surgery performed 7,000 miles away to the first blood test to help diagnose Alzheimer’s disease, 2025 has been a ...
A new study has proposed that Alzheimer’s disease can be successfully reversed instead of just being slowed down.
Experiments conducted in genetically engineered mice reinforce that CSE protein (ordinarily known for producing hydrogen ...
The free mobile app My ALZ Journey supports individuals newly diagnosed with Alzheimer’s and their caregivers.
FDA grants priority review to Axsome's AXS-05 for treating agitation in Alzheimer's disease with a PDUFA date of April 30, 2026.
More than 7 million Americans have Alzheimer's disease, and two-thirds of them are women, according to the Alzheimer's ...
Saying "you know" or "um" in conversation is normal. But over time, subtle changes in speech -- like pauses or those ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback